Commonwealth Bank increases stake in Australian Clinical Labs

Commonwealth Bank of Australia (CBA) and its related bodies corporate have reported a change in their substantial holding in Australian Clinical Labs Ltd (ACL). As of August 28, 2025, their total voting power in ACL stands at 7.29%, an increase from 6.16% on March 25, 2025. The total number of votes held by CBA and its associates has risen to 14,312,777 from 12,253,730.

The change reflects various transactions, including both purchases and sales of fully paid ordinary shares by Colonial First State Investments Limited, a related body corporate. Additionally, there were numerous "borrow increase" and "borrow decrease" transactions involving Commonwealth Bank of Australia for fully paid ordinary shares, indicating changes in their securities lending activities.

Notable purchases by Colonial First State Investments Limited include 150,000 shares for AUD 416,010.00 on June 16, 2025, and 162,700 shares for AUD 442,576.54 on August 26, 2025. Conversely, significant sales by Colonial First State Investments Limited occurred, such as 66,911 shares for AUD 183,064.75 on August 28, 2025. These movements collectively contributed to the overall increase in CBA's substantial holding.